BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Oct 13, 2008
 |  BC Week In Review  |  Clinical News  |  Regulatory

Ceplene histamine dihydrochloride regulatory update

The EC approved an MAA for Ceplene histamine from EpiCept for use in combination with interleukin-2 (IL-2) to maintain remission and prevent relapse...

Read the full 101 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >